Showing results (51-60 of 109) with videos related to
Sort By:
Pageof 11
Journal of Neurology|May 2, 2021
Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature reviewSimone Rossi, Elena Merli, Rita Rinaldi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2024
Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case ReportSimone Rossi, Roberta Costa, Alessandro di Federico, et al.Frontiers in Immunology|July 1, 2026
Case Report: The "atoll sign": a case series on an unusual radiological pattern of immune-mediated pneumonitisSamuele Compagno, Alessandro Di Federico, Andrea De Giglio, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2024
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-AnalysisDaniele Marinelli, Antonio Nuccio, Alessandro Di Federico, et al.Drugs in Context|August 17, 2022
Advanced non-small-cell lung cancer: how to manage <i>EGFR</i> and <i>HER2</i> exon 20 insertion mutation-positive diseaseGiulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.Lung Cancer (Amsterdam, Netherlands)|November 10, 2022
Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experienceAndrea De Giglio, Valeria Grandinetti, Marta Aprile, et al.Journal for Immunotherapy of Cancer|December 21, 2025
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancerXinan Wang, Biagio Ricciuti, Arielle Elkrief, et al.JTO Clinical and Research Reports|April 20, 2026
Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced <i>EGFR</i>-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient DataAlessandro Di Federico, Sara Stumpo, Linda Danielli, et al.Lung Cancer (Amsterdam, Netherlands)|April 8, 2025
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional studyAlice Avancini, Niccolò Giaj-Levra, Gabriele Minuti, et al.Journal of Neurology|February 17, 2023
Peripheral nervous system adverse events associated with immune checkpoint inhibitorsSimone Rossi, Francesco Gelsomino, Rita Rinaldi, et al.Pageof 11